StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Clodroninsure

Clodronate

HCID 25419
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
10596-23-3
Standard-SMILES
O=P(O)(O)C(Cl)(Cl)P(=O)(O)O
InChIKey
ACSIXWWBWUQEHA-UHFFFAOYSA-N
Summenformel
CH4Cl2O6P2
Durchschnittliche Molmasse
244,89 g/mol
Monoisotopische Masse
243,8860172

Überblick

Clodronic acid is an organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases. It has a role as an antineoplastic agent and a bone density conservation agent. It is an organochlorine compound, a one-carbon compound and a 1,1-bis(phosphonic acid). It is a conjugate acid of a clondronate(2-).

Namen und Bezeichner

Bevorzugter Name
Clodronate
IUPAC
[dichloro(phosphono)methyl]phosphonic acid
Lokaler Name
Clodroninsure
Englischer Name
Clodronic acid
Summenformel
CH4Cl2O6P2
Molmasse
244.89

Namen und Synonyme

Clodronic Acid10596-23-3Clodronate(Dichloromethylene)diphosphonic acidAcido clodronicoAcide clodroniqueAcidum clodronicumClodronsaeure[dichloro(phosphono)methyl]phosphonic acidDichloromethylidene diphosphonate(Dichloromethylene)bisphosphonic acidDichloromethanediphosphonic acid
Weitere Namen anzeigen
diphosphonic acidClodronicDichloromethylenebisphosphonic acid(Dichloromethylene)bis(phosphonic acid)ARC-69931Aids071014Aids-071014Clodronate AcidClodronic acid 18O3
Phosphonic acid, (dichloromethylene)bis-ClasteonLoron(Dichloro-phosphono-methyl)-phosphonic aciddichloromethylene-1,1-diphosphonic aciddichloromethylene-1,1-bisphosphonic acidDTXSID8046959Acid, Clodronic

Datenbank-Bezeichner

CAS
10596-23-3

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-2,1
Polarare Oberfläche (TPSA)
115 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
2
Schwere Atome
11
Formalladung
0
Komplexität
211

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

LogP-2.4
Solubility7.47e+00 g/L
Animal Drugs · 2 Einträge

FDA approved animal drugs -> Active ingredient

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Melting Point250 °C
Physical DescriptionSolid

Physikochemische Eigenschaften

Schmelzpunkt
249 · 249-251°
Siedepunkt
474.7 · 474.7±55.0 °C(Predicted)
Dichte
2.306 · 2.306±0.06 g/cm3(Predicted)
storage temp.
2 · under inert gas (nitrogen or Argon) at 2-8°C
Aggregatzustand
Solid

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

Health EffectsDecreases in serum calcium following substantial overdosage may be expected in some patients.
Exposure RoutesOral, Intravenous. After oral administration, absorption is estimated at 1–3% of the ingested dose because of the low uptake from the gastrointestinal tract.
Toxicity Summary · 1 Eintrag

The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a &beta;-&gamma;-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold <i>Dictyostelium discoideum</i> was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase.

Signs and SymptomsSigns and symptoms of hypocalcemia also may occur in some of these patients.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Clodronic acid

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

M05BA02

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingClodronic acid is 36% protein bound in plasma.
Pharmacodynamics · 1 Eintrag

Clodronic acid is a first generation bisphosphonate that inhibits osteoclast mediated bone resorption. It has a wide therapeutic index as a large overdose is required for significant toxicity and a long duration of action due to the slow release from bone. Patients should be counselled regarding the risk of hypocalcemia, hypovolemia, renal insufficiency, transient hyperphosphatemia, and transient hyperparathyroidism.

Mechanism of Action · 1 Eintrag

Bisphosphonates are taken into the bone where they bind to hydroxyapatite. Bone resorption by osteoclasts causes local acidification, releasing the bisphosphonate, which is taken into the osteoclast by fluid-phase endocytosis. Endocytic vesicles become acidified, releasing bisphosphonates into the cytosol of osteoclasts where they act. Osteoclasts mediate resorption of bone. When osteoclasts bind to bone they form podosomes, ring structures of F-actin. Disruption of the podosomes causes osteoclasts to detach from bones, preventing bone resorption. First generation bisphosphonates closely mimic the structure of pyrophosphate, which can be incorporated into ATP anologues that cannot be hydrolyzed, disrupting all ATP mediated actions of osteoclasts.

Biological Half-LifeThe mean plasma half life of clodronate is 5.6h.
Metabolism/Metabolites · 2 Einträge

Clodronate is not metabolized in humans.

Clodronate is not metabolized in humans. It can be metabolized intracellularly to a beta-gamma-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Half Life: Approximately 13 hours.

MeSH Pharmacological ClassificationAgents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Zugehörige Reaktionen

7
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 431286
HRID 431286als Edukt
Reaktionsgleichung von HRID 1157346
HRID 1157346als Produkt
Reaktionsgleichung von HRID 1181911
HRID 1181911als Produkt
Reaktionsgleichung von HRID 1182403
HRID 1182403als Edukt
Reaktionsgleichung von HRID 1602952
HRID 1602952als Edukt
Reaktionsgleichung von HRID 1602975
HRID 1602975als Edukt
Reaktionsgleichung von HRID 1817514
HRID 1817514als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
25419
DTXSID
DTXSID8046959
ChEMBL
CHEMBL12318
ChEBI
CHEBI:110423
UNII
0813BZ6866
EC Number
234-212-1
Nikkaji
J10.448E
pka
0.75 · 0.75±0.10(Predicted)
Farbe
Off-white to light yellow
InChI
InChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)
InChIKey
ACSIXWWBWUQEHA-UHFFFAOYSA-N
SMILES
C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl

Sicherheitsdaten

Alarmwort
Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H290
Absorption, Distribution and Excretion · 3 Einträge

Oral clodronic acid has a bioavailability of 1-2%. A 200mg intravenous dose reaches a Cmax of 16.1mg/L with an AUC of 44.2mg\*h/L. A 200mg intramuscular dose reaches a Cmax of 12.8mg/L with an AUC of 47.5mg\*h/L. Further pharmacokinetic data for clodronic acid are not readily available.

Clodronate is eliminated unchanged in the urine.

The renal clearance of clodronate is approximately 90mL/min.

Cellular LocationsCytoplasm

Verwendung und Herstellung

Uses · 2 Einträge

Use (kg; approx.) in Germany (2009): >500

A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. For the management of hypercalcemia of malignancy and as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.

Anwendungen

VerwendenClodronic Acid is a bisphosphonate that can be used in the treatment of osteoporosis. Its ATP-analogs can inhibit cell signaling pathways.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Dibrommethan
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: An organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the trea ment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases.